BioRender 图标

Pseudostratified epithelium cell 2 (ciliated)

Pseudostratified epithelium cell 2 (ciliated) - Editable icon of Pseudostratified epithelium cell 2 (ciliated)
[{"image":"https://icons.cdn.biorender.com/w75xh75/66df478aed9462577e08bb83/5ed8f782cf94560026521bf9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df478aed9462577e08bb83/5ed8f782cf94560026521bf9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df478aed9462577e08bb84/5ed8f782cf94560026521bf9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df478aed9462577e08bb84/5ed8f782cf94560026521bf9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df478aed9462577e08bb85/5ed8f782cf94560026521bf9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df478aed9462577e08bb85/5ed8f782cf94560026521bf9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df478aed9462577e08bb86/5ed8f782cf94560026521bf9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df478aed9462577e08bb86/5ed8f782cf94560026521bf9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df478aed9462577e08bb87/5ed8f782cf94560026521bf9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df478aed9462577e08bb87/5ed8f782cf94560026521bf9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df478aed9462577e08bb88/5ed8f782cf94560026521bf9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df478aed9462577e08bb88/5ed8f782cf94560026521bf9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df478aed9462577e08bb89/5ed8f782cf94560026521bf9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df478aed9462577e08bb89/5ed8f782cf94560026521bf9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df478aed9462577e08bb8a/5ed8f782cf94560026521bf9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df478aed9462577e08bb8a/5ed8f782cf94560026521bf9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df478aed9462577e08bb8b/5ed8f782cf94560026521bf9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df478aed9462577e08bb8b/5ed8f782cf94560026521bf9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df478aed9462577e08bb8c/5ed8f782cf94560026521bf9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df478aed9462577e08bb8c/5ed8f782cf94560026521bf9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df478aed9462577e08bb8d/5ed8f782cf94560026521bf9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df478aed9462577e08bb8d/5ed8f782cf94560026521bf9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df478aed9462577e08bb8e/5ed8f782cf94560026521bf9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df478aed9462577e08bb8e/5ed8f782cf94560026521bf9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df478aed9462577e08bb8f/5ed8f782cf94560026521bf9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df478aed9462577e08bb8f/5ed8f782cf94560026521bf9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df478aed9462577e08bb90/5ed8f782cf94560026521bf9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df478aed9462577e08bb90/5ed8f782cf94560026521bf9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df478aed9462577e08bb91/5ed8f782cf94560026521bf9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df478aed9462577e08bb91/5ed8f782cf94560026521bf9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df478aed9462577e08bb92/5ed8f782cf94560026521bf9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df478aed9462577e08bb92/5ed8f782cf94560026521bf9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df478aed9462577e08bb93/5ed8f782cf94560026521bf9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df478aed9462577e08bb93/5ed8f782cf94560026521bf9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df478aed9462577e08bb94/5ed8f782cf94560026521bf9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df478aed9462577e08bb94/5ed8f782cf94560026521bf9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df478aed9462577e08bb95/5ed8f782cf94560026521bf9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df478aed9462577e08bb95/5ed8f782cf94560026521bf9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df478aed9462577e08bb96/5ed8f782cf94560026521bf9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df478aed9462577e08bb96/5ed8f782cf94560026521bf9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df478aed9462577e08bb97/5ed8f782cf94560026521bf9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df478aed9462577e08bb97/5ed8f782cf94560026521bf9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df478aed9462577e08bb98/5ed8f782cf94560026521bf9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df478aed9462577e08bb98/5ed8f782cf94560026521bf9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df478aed9462577e08bb99/5ed8f782cf94560026521bf9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df478aed9462577e08bb99/5ed8f782cf94560026521bf9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df478aed9462577e08bb9a/5ed8f782cf94560026521bf9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df478aed9462577e08bb9a/5ed8f782cf94560026521bf9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df478aed9462577e08bb9b/5ed8f782cf94560026521bf9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df478aed9462577e08bb9b/5ed8f782cf94560026521bf9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df478aed9462577e08bb9c/5ed8f782cf94560026521bf9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df478aed9462577e08bb9c/5ed8f782cf94560026521bf9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df478aed9462577e08bb9d/5ed8f782cf94560026521bf9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df478aed9462577e08bb9d/5ed8f782cf94560026521bf9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df478aed9462577e08bb9e/5ed8f782cf94560026521bf9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df478aed9462577e08bb9e/5ed8f782cf94560026521bf9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df478aed9462577e08bb9f/5ed8f782cf94560026521bf9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df478aed9462577e08bb9f/5ed8f782cf94560026521bf9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df478aed9462577e08bba0/5ed8f782cf94560026521bf9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df478aed9462577e08bba0/5ed8f782cf94560026521bf9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df478aed9462577e08bba1/5ed8f782cf94560026521bf9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df478aed9462577e08bba1/5ed8f782cf94560026521bf9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df478aed9462577e08bba2/5ed8f782cf94560026521bf9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df478aed9462577e08bba2/5ed8f782cf94560026521bf9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df478aed9462577e08bba3/5ed8f782cf94560026521bf9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df478aed9462577e08bba3/5ed8f782cf94560026521bf9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df478aed9462577e08bba4/5ed8f782cf94560026521bf9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df478aed9462577e08bba4/5ed8f782cf94560026521bf9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df478aed9462577e08bba5/5ed8f782cf94560026521bf9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df478aed9462577e08bba5/5ed8f782cf94560026521bf9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df478aed9462577e08bba6/5ed8f782cf94560026521bf9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df478aed9462577e08bba6/5ed8f782cf94560026521bf9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df478aed9462577e08bba7/5ed8f782cf94560026521bf9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df478aed9462577e08bba7/5ed8f782cf94560026521bf9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df478aed9462577e08bba8/5ed8f782cf94560026521bf9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df478aed9462577e08bba8/5ed8f782cf94560026521bf9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df478aed9462577e08bba9/5ed8f782cf94560026521bf9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df478aed9462577e08bba9/5ed8f782cf94560026521bf9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df478aed9462577e08bbaa/5ed8f782cf94560026521bf9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df478aed9462577e08bbaa/5ed8f782cf94560026521bf9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df478aed9462577e08bbab/5ed8f782cf94560026521bf9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df478aed9462577e08bbab/5ed8f782cf94560026521bf9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df478aed9462577e08bbac/5ed8f782cf94560026521bf9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df478aed9462577e08bbac/5ed8f782cf94560026521bf9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df478aed9462577e08bbad/5ed8f782cf94560026521bf9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df478aed9462577e08bbad/5ed8f782cf94560026521bf9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df478aed9462577e08bbae/5ed8f782cf94560026521bf9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df478aed9462577e08bbae/5ed8f782cf94560026521bf9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df478aed9462577e08bbaf/5ed8f782cf94560026521bf9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df478aed9462577e08bbaf/5ed8f782cf94560026521bf9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df478aed9462577e08bbb0/5ed8f782cf94560026521bf9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df478aed9462577e08bbb0/5ed8f782cf94560026521bf9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df478aed9462577e08bbb1/5ed8f782cf94560026521bf9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df478aed9462577e08bbb1/5ed8f782cf94560026521bf9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df478aed9462577e08bbb2/5ed8f782cf94560026521bf9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df478aed9462577e08bbb2/5ed8f782cf94560026521bf9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df478aed9462577e08bbb3/5ed8f782cf94560026521bf9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df478aed9462577e08bbb3/5ed8f782cf94560026521bf9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66df478aed9462577e08bbb4/5ed8f782cf94560026521bf9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66df478aed9462577e08bbb4/5ed8f782cf94560026521bf9.png"}]
使用此图标 – 免费
注册无需信用卡。

此图标可在 BioRender 中完全编辑

  • 添加文本、形状及其他图标
  • 搜索 50,000 多种科学准确的图标
  • 重新着色并重新排列每一个图标、线条和标签
  • 导出或分享以满足任何使用需求
Scientist Avatars

加入 400 多万名科学家 的行列,制作可直接用于发表的图表

从图标到成品图表,只需几分钟

  • 搜索 来自 50,000 多个科学准确、经同行评审的图标
  • 自定义 添加标签、形状和更多图标——一切皆可完全编辑
  • 导出 或与协作者分享您的图表
    ‍

图标不合适?探索更多内容。

搜索涵盖 30 多个生命科学领域的 50,000 多个图标。

search icon
arrow-right
pseudostratified,columnar,ciliated,pseudostratified
查看更多

尝试使用同义词,或注册以在应用中请求图标。

图像类型

Pseudostratified epithelium cell 2 (ciliated) icon JPEG

Pseudostratified epithelium cell 2 (ciliated) icon PNG

Pseudostratified epithelium cell 2 (ciliated) icon SVG

Pseudostratified epithelium cell 2 (ciliated) icon GIF

BioRender 图标常见问题解答

How are scientists using the Pseudostratified epithelium cell 2 (ciliated) icon in their work?

BioRender users often use the Pseudostratified epithelium cell 2 (ciliated) icon in posters, grant applications, educational materials, and graphical abstracts. It’s especially useful for projects involving Cell Types.

我可以在 BioRender 图表或科学插图中使用此图标吗?

Yes, the Pseudostratified epithelium cell 2 (ciliated) is fully integrated into BioRender’s drag-and-drop platform. You can easily add it to any scientific figure, workflow, or poster, whether you’re building from scratch or starting with a BioRender template.

Is the Pseudostratified epithelium cell 2 (ciliated) icon customizable in BioRender?

Most icons in BioRender, including the Pseudostratified epithelium cell 2 (ciliated) icon, are customizable. You can adjust icon size, colors, and positioning, and add custom labels to tailor the design to your specific research context.

Can I export figures that include the Pseudostratified epithelium cell 2 (ciliated) icon for publication or presentations?

Yes, figures containing the Pseudostratified epithelium cell 2 (ciliated) icon can be exported in multiple formats, including PNG, JPG, PDF, and SVG. High-resolution and vector exports are available on paid plans, making them ideal for journals, slide decks, and print materials.

How do I cite BioRender if I use this icon?

Unlock publication permissions with a paid plan, and include 'Created with BioRender.com' in your figure legend, or cite BioRender directly per your journal's guidelines.

Is the Pseudostratified epithelium cell 2 (ciliated) icon used in BioRender templates or poster layouts?

Many BioRender templates include icons like the Pseudostratified epithelium cell 2 (ciliated) icon — especially those focused on Cell Types. You can search BioRender’s template library or add this icon manually to any canvas.

什么是 BioRender?

BioRender is a web‑based software that helps you create scientific figures in minutes. Use this Pseudostratified epithelium cell 2 (ciliated) icon along with our library of more than 30,000 life science icons.

在 BioRender 中使用此图标

立即开始制作专业的科学图表
antibody elements3D Phospholipid illustration

正在寻找科学内容?

浏览超过 5 万个经同行评审、易于使用且免费的图标和模板。

立即寻找您的专属素材
x icon